SITC Resource Library

Case Studies in Immunotherapy for the Treatment of Renal Cell Carcinoma – SITC CPG Webinar Recording and Presentation Slides 

12-14-2021 13:26

On January 20, 2022, leading experts from the SITC Renal Cell Carcinoma Guideline Expert Panel presented "Case Studies in Immunotherapy for the Treatment of Renal Cell Carcinoma – SITC CPG Webinar." This high-level webinar included case studies that illustrated execution of the Clinical Practice Guideline (CPG) and discussed difficult topics related to case management. The recorded webinar and presentation slides are available below.

Webinar Faculty:

  • Moderator: Michael B. Atkins, MD — Georgetown Lombardi Comprehensive Cancer Center (Expert Panel Chair)
  • Virginia Seery, MSN, RN, ANP, AOCNP — Beth Israel Deaconess Medical Center (Expert Panel Member)
  • Martin H. Voss, MD – Memorial Sloan Kettering Cancer Center (Expert Panel Member)

        Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org, or check out our free CPG mobile app.


        The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).

        The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.


        #RenalCellCarcinoma #PresentationSlides #RecordedWebinar #ClinicalPracticeGuideline #2022​​

        Statistics
        0 Favorited
        43 Views
        2 Files
        0 Shares
        13 Downloads
        Attachment(s)
        pdf file
        Case Studies in Immunotherapy for the Treatment of Renal ...   3.42 MB   1 version
        Uploaded - 02-17-2022
        mp4 file
        Case Studies in Immunotherapy for the Treatment of Renal ...   640.76 MB   1 version
        Uploaded - 02-25-2022

        Related Entries and Links

        No Related Resource entered.